Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1971 1
1972 1
1973 2
1975 3
1976 1
1977 3
1978 1
1979 5
1980 4
1981 1
1982 4
1983 10
1984 6
1985 2
1986 6
1987 5
1988 6
1989 14
1990 19
1991 27
1992 30
1993 51
1994 37
1995 58
1996 48
1997 52
1998 60
1999 46
2000 45
2001 37
2002 46
2003 32
2004 48
2005 48
2006 56
2007 44
2008 49
2009 59
2010 95
2011 103
2012 118
2013 101
2014 115
2015 92
2016 85
2017 107
2018 92
2019 82
2020 96
2021 79
2022 71
2023 58
2024 23

Text availability

Article attribute

Article type

Publication date

Search Results

2,095 results

Results by year

Filters applied: . Clear all
Page 1
PD-L1/TLR7 dual-targeting nanobody-drug conjugate mediates potent tumor regression via elevating tumor immunogenicity in a host-expressed PD-L1 bias-dependent way.
Yu X, Long Y, Chen B, Tong Y, Shan M, Jia X, Hu C, Liu M, Zhou J, Tang F, Lu H, Chen R, Xu P, Huang W, Ren J, Wan Y, Sun J, Li J, Jin G, Gong L. Yu X, et al. J Immunother Cancer. 2022 Oct;10(10):e004590. doi: 10.1136/jitc-2022-004590. J Immunother Cancer. 2022. PMID: 36253000 Free PMC article.
Nanobody against PDL1.
Li S, Jiang K, Wang T, Zhang W, Shi M, Chen B, Hua Z. Li S, et al. Biotechnol Lett. 2020 May;42(5):727-736. doi: 10.1007/s10529-020-02823-2. Epub 2020 Jan 31. Biotechnol Lett. 2020. PMID: 32006351
Immunoglobulin Fab fragment-binding proteins.
Bouvet JP. Bouvet JP. Int J Immunopharmacol. 1994 May-Jun;16(5-6):419-24. doi: 10.1016/0192-0561(94)90031-0. Int J Immunopharmacol. 1994. PMID: 7927988 Review.
Nanobodies as probes to investigate purinergic signaling.
Eggers M, Rühl F, Haag F, Koch-Nolte F. Eggers M, et al. Biochem Pharmacol. 2021 May;187:114394. doi: 10.1016/j.bcp.2020.114394. Epub 2021 Jan 1. Biochem Pharmacol. 2021. PMID: 33388283 Review.
2,095 results